Barr Scraps Seasonale Ad Revisions, Starts On New DTC Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
The company attributes a slowdown in growth for the extended-regimen oral contraceptive to the hiatus in direct-to-consumer advertising. The DTC spots were pulled after FDA objected to the original ad and the revised version. New ads will debut in late spring or early summer, CEO Downey says.
You may also be interested in...
Barr Launches New Seasonale Ad, Increases Emphasis On Safety Risks
The third version of Barr’s television ad responds to issues previously objected to by FDA’s ad division.
Barr Launches New Seasonale Ad, Increases Emphasis On Safety Risks
The third version of Barr’s television ad responds to issues previously objected to by FDA’s ad division.
Barr To File Seasonale Lo NDA By June 30
As Barr prepares to extend the Seasonale franchise, the company will introduce a new DTC TV campaign for the original formulation in late June or early July after FDA signs off on the ads. The company anticipates launching Seasonique in the fall, pending FDA approval of the extended-regimen contraceptive.